Two people who have been blind since childhood are having their vision restored with a gene therapy developed by University of Florida Health scientists and their collaborators, early-stage clinical trial results and recently published findings show.
Dr. Shannon Boye joins Beacon Story Podcast for the Community Storytelling show in partnership with the Foundation Fighting Blindness.
Congratulations to Dr. Kaitlyn Calabro for her receipt of the competitive NIH Pediatric Loan Repayment Program award! Kait’s award will relieve the stress of paying back student loans while she conducts her postdoctoral studies to develop a gene therapy for MYO7A- associated Usher syndrome (USH1B). The NIH Loan Repayment Programs…
Shannon Boye, a scientist at the University of Florida, is the co-founder of a new gene-therapy startup in Durham called Atsena Therapeutics. The company is making a therapy for a disease called LCA that causes blindness.
Participants of Virtual VISIONS 2020 are invited to join live for the opening presentation, “Mission Possible! What’s Next for Gene Therapy?” presented by Dr. Shannon Boye,…
Unstoppable Minds features the real stories of students and faculty overcoming challenges to tackle the world’s greatest obstacles. It dives into the breakthroughs and backstories of the people powering real world change from the University of Florida. Dr. Boye talks about her journey in academia and what led her to…
#GivingTuesdayNow Featured Researcher Dr. Shannon Boye…
Dr. Boye, Dr. Calabro, Dr. Crosson, Siddhant (‘Sid’) Gupte and Russell Mellen all had the pleasure of presenting their newest data at the first virtual ASGCT meeting. Dr. Boye gave an update on the novel AAV capsids she has developed for intravitreal injection. Dr. Calabro…
COVID-19 has changed everything. I’ve become a 6th and 4th grade teacher on top of being a PI. My students, postdocs, and staff have carefully navigated social distancing rules to do a much reduced number of experiments, but have made up for time lost in lab by writing grants and…
Today, Feb. 28th, the BLM helped celebrate Rare Disease Day. Russell Mellen presented his work to develop an AAV-CRISPR/Cas9- based approach for a pediatric retinal disease, cone-rod dystrophy. Dr. Kaitlyn Calabro presented her work to develop a dual AAV vector-mediated therapy for MYO7A Usher syndrome. We also took…
